Insider Transactions in Q2 2024 at Axsome Therapeutics, Inc. (AXSM)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 29
2024
|
Mark Coleman |
SELL
Open market or private sale
|
Direct |
5,248
-26.44%
|
$393,600
$75.14 P/Share
|
|
May 29
2024
|
Mark L. Jacobson Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,910
-57.77%
|
$585,340
$74.31 P/Share
|
|
May 29
2024
|
Mark L. Jacobson Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,693
+50.0%
|
$13,693
$1.3 P/Share
|
|
May 28
2024
|
Mark Coleman |
SELL
Open market or private sale
|
Direct |
5,249
-20.91%
|
$393,675
$75.21 P/Share
|
|
Apr 01
2024
|
Mark L. Jacobson Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
24,662
-100.0%
|
$1,898,974
$77.24 P/Share
|
|
Apr 01
2024
|
Mark L. Jacobson Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,662
+50.0%
|
$24,662
$1.3 P/Share
|